Fit-for-Purpose COA Development: 25 years developing, modifying and validating PROs in more than 60 therapeutic categories. LEARN MORE

Translation Services: 25 years developing linguistically validated translations of COAs, CRFs, protocols, manuals, etc… READ MORE

QualityMetric By The Numbers: 41,000,000+ Global Survey administrations, 40,000+ Peer-reviewed articles across 100+ conditions, 2,000+ Language translations by mode of administrations, 100+ Condition-Specific, Country-Specific, and Insurance Claims Benchmarks General Population Norms. Which survey should you use? SEE OUR SUITE OF PRO SURVEYS

ePRO & EDC Integration: Seamless integration for optimal efficiencies using Web Service Application Programming Interface (API), Single Sign-on Access (SSO) or Electronic-Friendly Survey Administration. FIND OUT HOW

News

01.03.21

QualityMetric Collaborates with Drug Developers to Address Pain Points of Rare Diseases

QualityMetric collaborates with drug developers to address pain points of rare diseases

We offer several patient-reported outcome (PRO) measurement solutions that can help document the etiology, progression, patient experience, symptoms and impact of rare diseases.

 

On rare disease research

Drug developers face many unique challenges in developing rare disease treatments: natural history is often poorly understood and characterized, diseases tend to be life-limiting, small populations restrict study design and replication. They’re also challenged by the lack of validated tools to assess outcomes. 

 

QualityMetric offers several patient-reported outcome (PRO) measurement solutions that can help developers of drugs for rare diseases address these pain points. Our solutions can help document the etiology, progression, patient experience, symptoms and impact of rare diseases.

 

Our disease-specific surveys allow you to engage meaningfully with patient advocacy groups for recruitment and help gather critical information about the patient experience and unmet need for treatment, and inform the selection of endpoints for efficacy trials.

 

QualityMetric’s PRO solutions can help you meet FDA recommendations to document the natural history of rare diseases via qualitative research studies.